John Harry Cross III

Insider Reports History

Entity
Individual
Location
C/O Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton, NJ
Signature
/s/ John Harry Cross III
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Harry Cross III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sonnet BioTherapeutics Holdings, Inc. Chief Financial Officer Common Stock 1.59K $1.11K $0.70 Dec 11, 2023 Direct

Insider Reports Filed by John Harry Cross III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 11, 2023 1 $0 4 Dec 5, 2024 Chief Financial Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Feb 6, 2023 1 -$2.08K 4 Feb 17, 2023 Chief Financial Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 14, 2022 1 $0 4 Dec 22, 2022 Chief Financial Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 15, 2021 1 $0 4 Apr 8, 2022 Chief Financial Officer